>>Gilead will probably work out a deal with NICE for TAF regimes just like they came to an agreement with Sovaldi ? I think it will be much harder for TAF than for Sovaldi. The delta to the next-best treatment is just so much smaller for TAF than for Sovaldi. GILD will still very much be playing defense in HIV - slowing the decline is the best they can hope for. Peter